APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lisdexamfetamine Dimesylate Capsules

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Lisdexamfetamine Dimesylate Capsules Market Outlook and Growth Opportunities 2026

27 December 2025192 pages

Choose your research edition.

Industry ResearchLisdexamfetamine Dimesylate Capsules Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Lisdexamfetamine Dimesylate Capsules Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Lisdexamfetamine Dimesylate Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lisdexamfetamine Dimesylate Capsules Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Lisdexamfetamine Dimesylate Capsules Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Lisdexamfetamine Dimesylate Capsules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Lisdexamfetamine Dimesylate Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Lisdexamfetamine Dimesylate Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lisdexamfetamine Dimesylate Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Lisdexamfetamine Dimesylate Capsules market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Lisdexamfetamine Dimesylate Capsules market include Zhejiang Huahai Pharmaceutical, Sun Pharmaceutical, Takeda Pharmaceutical, Teva Pharmaceutical, Sandoz, Mylan, Mallinckrodt PLC, Lannett and Hikma Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Lisdexamfetamine Dimesylate Capsules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lisdexamfetamine Dimesylate Capsules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lisdexamfetamine Dimesylate Capsules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Lisdexamfetamine Dimesylate Capsules market size, projected growth trends, production technologies, key applications, and end-use industries.

Lisdexamfetamine Dimesylate Capsules Segment by Company

Zhejiang Huahai Pharmaceutical

Sun Pharmaceutical

Takeda Pharmaceutical

Teva Pharmaceutical

Sandoz

Mylan

Mallinckrodt PLC

Lannett

Hikma Pharmaceuticals

Ascent Pharmaceuticals

Apotex

Amneal Pharmaceuticals

Alkem Laboratories

Lisdexamfetamine Dimesylate Capsules Segment by Type

10mg per Unit

20mg per Unit

30mg per Unit

40mg per Unit

50mg per Unit

60mg per Unit

70mg per Unit

Lisdexamfetamine Dimesylate Capsules Segment by Application

Attention Deficit Hyperactivity Disorder(ADHD)

Bulimia

Other

Lisdexamfetamine Dimesylate Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Lisdexamfetamine Dimesylate Capsules status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Lisdexamfetamine Dimesylate Capsules market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Lisdexamfetamine Dimesylate Capsules significant trends, drivers, influence factors in global and regions.

6. To analyze Lisdexamfetamine Dimesylate Capsules competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lisdexamfetamine Dimesylate Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lisdexamfetamine Dimesylate Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lisdexamfetamine Dimesylate Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Lisdexamfetamine Dimesylate Capsules market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Lisdexamfetamine Dimesylate Capsules industry.

Chapter 3: Detailed analysis of Lisdexamfetamine Dimesylate Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Lisdexamfetamine Dimesylate Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Lisdexamfetamine Dimesylate Capsules in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Lisdexamfetamine Dimesylate Capsules Industry Trends Table 2. Lisdexamfetamine Dimesylate Capsules Industry Drivers Table 3. Lisdexamfetamine Dimesylate Capsules Industry Opportunities and Challenges Table 4. Lisdexamfetamine Dimesylate Capsules Industry Restraints Table 5. Global Lisdexamfetamine Dimesylate Capsules Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Lisdexamfetamine Dimesylate Capsules Revenue Share by Company (2021-2026) Table 7. Global Lisdexamfetamine Dimesylate Capsules Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Lisdexamfetamine Dimesylate Capsules Sales Volume Share by Company (2021-2026) Table 9. Global Lisdexamfetamine Dimesylate Capsules Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Lisdexamfetamine Dimesylate Capsules Company Ranking, (2024-2026) & (USD Million) Table 11. Global Lisdexamfetamine Dimesylate Capsules Key Company Manufacturing Base & Headquarters Table 12. Global Lisdexamfetamine Dimesylate Capsules Company, Product Type & Application Table 13. Global Lisdexamfetamine Dimesylate Capsules Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Lisdexamfetamine Dimesylate Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 10mg per Unit Table 18. Significant Companies of 20mg per Unit Table 19. Significant Companies of 30mg per Unit Table 20. Significant Companies of 40mg per Unit Table 21. Significant Companies of 50mg per Unit Table 22. Significant Companies of 60mg per Unit Table 23. Significant Companies of 70mg per Unit Table 24. Global Lisdexamfetamine Dimesylate Capsules Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Lisdexamfetamine Dimesylate Capsules Sales Volume by Type (2021-2026) & (K Units) Table 26. Global Lisdexamfetamine Dimesylate Capsules Sales Volume by Type (2027-2032) & (K Units) Table 27. Global Lisdexamfetamine Dimesylate Capsules Sales Volume Share by Type (2021-2026) Table 28. Global Lisdexamfetamine Dimesylate Capsules Sales Volume Share by Type (2027-2032) Table 29. Global Lisdexamfetamine Dimesylate Capsules Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Lisdexamfetamine Dimesylate Capsules Sales Value by Type (2021-2026) & (US$ Million) Table 31. Global Lisdexamfetamine Dimesylate Capsules Sales Value by Type (2027-2032) & (US$ Million) Table 32. Global Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type (2021-2026) Table 33. Global Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type (2027-2032) Table 34. Significant Companies of Attention Deficit Hyperactivity Disorder(ADHD) Table 35. Significant Companies of Bulimia Table 36. Significant Companies of Other Table 37. Global Lisdexamfetamine Dimesylate Capsules Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Lisdexamfetamine Dimesylate Capsules Sales Volume by Application (2021-2026) & (K Units) Table 39. Global Lisdexamfetamine Dimesylate Capsules Sales Volume by Application (2027-2032) & (K Units) Table 40. Global Lisdexamfetamine Dimesylate Capsules Sales Volume Share by Application (2021-2026) Table 41. Global Lisdexamfetamine Dimesylate Capsules Sales Volume Share by Application (2027-2032) Table 42. Global Lisdexamfetamine Dimesylate Capsules Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global Lisdexamfetamine Dimesylate Capsules Sales Value by Application (2021-2026) & (US$ Million) Table 44. Global Lisdexamfetamine Dimesylate Capsules Sales Value by Application (2027-2032) & (US$ Million) Table 45. Global Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application (2021-2026) Table 46. Global Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application (2027-2032) Table 47. Global Lisdexamfetamine Dimesylate Capsules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 48. Global Lisdexamfetamine Dimesylate Capsules Sales by Region (2021-2026) & (K Units) Table 49. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Region (2021-2026) Table 50. Global Lisdexamfetamine Dimesylate Capsules Sales by Region (2027-2032) & (K Units) Table 51. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Region (2027-2032) Table 52. Global Lisdexamfetamine Dimesylate Capsules Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Lisdexamfetamine Dimesylate Capsules Sales Value by Region (2021-2026) & (US$ Million) Table 54. Global Lisdexamfetamine Dimesylate Capsules Sales Value Share by Region (2021-2026) Table 55. Global Lisdexamfetamine Dimesylate Capsules Sales Value by Region (2027-2032) & (US$ Million) Table 56. Global Lisdexamfetamine Dimesylate Capsules Sales Value Share by Region (2027-2032) Table 57. Global Lisdexamfetamine Dimesylate Capsules Market Average Price (US$/Unit) by Region (2021-2026) Table 58. Global Lisdexamfetamine Dimesylate Capsules Market Average Price (US$/Unit) by Region (2027-2032) Table 59. Global Lisdexamfetamine Dimesylate Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 60. Global Lisdexamfetamine Dimesylate Capsules Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Lisdexamfetamine Dimesylate Capsules Sales by Country (2021-2026) & (K Units) Table 62. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Country (2021-2026) Table 63. Global Lisdexamfetamine Dimesylate Capsules Sales by Country (2027-2032) & (K Units) Table 64. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Country (2027-2032) Table 65. Global Lisdexamfetamine Dimesylate Capsules Sales Value by Country (2021-2026) & (US$ Million) Table 66. Global Lisdexamfetamine Dimesylate Capsules Sales Value Market Share by Country (2021-2026) Table 67. Global Lisdexamfetamine Dimesylate Capsules Sales Value by Country (2027-2032) & (US$ Million) Table 68. Global Lisdexamfetamine Dimesylate Capsules Sales Value Market Share by Country (2027-2032) Table 69. Zhejiang Huahai Pharmaceutical Company Information Table 70. Zhejiang Huahai Pharmaceutical Business Overview Table 71. Zhejiang Huahai Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Zhejiang Huahai Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 73. Zhejiang Huahai Pharmaceutical Recent Development Table 74. Sun Pharmaceutical Company Information Table 75. Sun Pharmaceutical Business Overview Table 76. Sun Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Sun Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 78. Sun Pharmaceutical Recent Development Table 79. Takeda Pharmaceutical Company Information Table 80. Takeda Pharmaceutical Business Overview Table 81. Takeda Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Takeda Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 83. Takeda Pharmaceutical Recent Development Table 84. Teva Pharmaceutical Company Information Table 85. Teva Pharmaceutical Business Overview Table 86. Teva Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Teva Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 88. Teva Pharmaceutical Recent Development Table 89. Sandoz Company Information Table 90. Sandoz Business Overview Table 91. Sandoz Lisdexamfetamine Dimesylate Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Sandoz Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 93. Sandoz Recent Development Table 94. Mylan Company Information Table 95. Mylan Business Overview Table 96. Mylan Lisdexamfetamine Dimesylate Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Mylan Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 98. Mylan Recent Development Table 99. Mallinckrodt PLC Company Information Table 100. Mallinckrodt PLC Business Overview Table 101. Mallinckrodt PLC Lisdexamfetamine Dimesylate Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Mallinckrodt PLC Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 103. Mallinckrodt PLC Recent Development Table 104. Lannett Company Information Table 105. Lannett Business Overview Table 106. Lannett Lisdexamfetamine Dimesylate Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Lannett Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 108. Lannett Recent Development Table 109. Hikma Pharmaceuticals Company Information Table 110. Hikma Pharmaceuticals Business Overview Table 111. Hikma Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Hikma Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 113. Hikma Pharmaceuticals Recent Development Table 114. Ascent Pharmaceuticals Company Information Table 115. Ascent Pharmaceuticals Business Overview Table 116. Ascent Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Ascent Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 118. Ascent Pharmaceuticals Recent Development Table 119. Apotex Company Information Table 120. Apotex Business Overview Table 121. Apotex Lisdexamfetamine Dimesylate Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Apotex Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 123. Apotex Recent Development Table 124. Amneal Pharmaceuticals Company Information Table 125. Amneal Pharmaceuticals Business Overview Table 126. Amneal Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Amneal Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 128. Amneal Pharmaceuticals Recent Development Table 129. Alkem Laboratories Company Information Table 130. Alkem Laboratories Business Overview Table 131. Alkem Laboratories Lisdexamfetamine Dimesylate Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Alkem Laboratories Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 133. Alkem Laboratories Recent Development Table 134. Key Raw Materials Table 135. Raw Materials Key Suppliers Table 136. Lisdexamfetamine Dimesylate Capsules Distributors List Table 137. Lisdexamfetamine Dimesylate Capsules Customers List Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources Table 141. Primary Sources List of Figures Figure 1. Lisdexamfetamine Dimesylate Capsules Product Image Figure 2. Global Lisdexamfetamine Dimesylate Capsules Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lisdexamfetamine Dimesylate Capsules Sales Value (2021-2032) & (US$ Million) Figure 4. Global Lisdexamfetamine Dimesylate Capsules Sales (2021-2032) & (K Units) Figure 5. Global Lisdexamfetamine Dimesylate Capsules Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Lisdexamfetamine Dimesylate Capsules Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 10mg per Unit Image Figure 10. 20mg per Unit Image Figure 11. 30mg per Unit Image Figure 12. 40mg per Unit Image Figure 13. 50mg per Unit Image Figure 14. 60mg per Unit Image Figure 15. 70mg per Unit Image Figure 16. Global Lisdexamfetamine Dimesylate Capsules Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Lisdexamfetamine Dimesylate Capsules Sales Volume Share 2021 VS 2025 VS 2032 Figure 18. Global Lisdexamfetamine Dimesylate Capsules Sales Volume Share by Type (2021-2032) Figure 19. Global Lisdexamfetamine Dimesylate Capsules Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Lisdexamfetamine Dimesylate Capsules Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type (2021-2032) Figure 22. Attention Deficit Hyperactivity Disorder(ADHD) Image Figure 23. Bulimia Image Figure 24. Other Image Figure 25. Global Lisdexamfetamine Dimesylate Capsules Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Lisdexamfetamine Dimesylate Capsules Sales Volume Share 2021 VS 2025 VS 2032 Figure 27. Global Lisdexamfetamine Dimesylate Capsules Sales Volume Share by Application (2021-2032) Figure 28. Global Lisdexamfetamine Dimesylate Capsules Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Lisdexamfetamine Dimesylate Capsules Sales Value Share 2021 VS 2025 VS 2032 Figure 30. Global Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application (2021-2032) Figure 31. Global Lisdexamfetamine Dimesylate Capsules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 32. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 33. Global Lisdexamfetamine Dimesylate Capsules Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 34. Global Lisdexamfetamine Dimesylate Capsules Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 35. North America Lisdexamfetamine Dimesylate Capsules Sales Value (2021-2032) & (US$ Million) Figure 36. North America Lisdexamfetamine Dimesylate Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Europe Lisdexamfetamine Dimesylate Capsules Sales Value (2021-2032) & (US$ Million) Figure 38. Europe Lisdexamfetamine Dimesylate Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Asia-Pacific Lisdexamfetamine Dimesylate Capsules Sales Value (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Lisdexamfetamine Dimesylate Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 41. South America Lisdexamfetamine Dimesylate Capsules Sales Value (2021-2032) & (US$ Million) Figure 42. South America Lisdexamfetamine Dimesylate Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 43. Middle East & Africa Lisdexamfetamine Dimesylate Capsules Sales Value (2021-2032) & (US$ Million) Figure 44. Middle East & Africa Lisdexamfetamine Dimesylate Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 45. USA Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. USA Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. USA Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Canada Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Canada Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Canada Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Mexico Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Mexico Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Mexico Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Germany Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Germany Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Germany Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. France Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. France Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. France Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. U.K. Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. U.K. Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. U.K. Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Italy Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Italy Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Italy Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Spain Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Spain Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Spain Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Russia Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Russia Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Russia Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Netherlands Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Netherlands Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Netherlands Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Nordic Countries Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Nordic Countries Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Nordic Countries Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. China Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. China Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. China Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Japan Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Japan Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Japan Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. South Korea Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. South Korea Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. South Korea Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. India Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. India Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. India Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Australia Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Australia Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Australia Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Southeast Asia Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Southeast Asia Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Southeast Asia Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Brazil Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Brazil Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Brazil Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Argentina Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Argentina Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Argentina Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Chile Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Chile Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Chile Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Colombia Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Colombia Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Colombia Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Peru Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Peru Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Peru Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Saudi Arabia Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Israel Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Israel Arabia Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Israel Arabia Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. UAE Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. UAE Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. UAE Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Turkey Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Turkey Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Turkey Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Iran Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Iran Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Iran Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Egypt Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 127. Egypt Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 128. Egypt Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 129. Lisdexamfetamine Dimesylate Capsules Value Chain Figure 130. Manufacturing Cost Structure Figure 131. Lisdexamfetamine Dimesylate Capsules Sales Mode & Process Figure 132. Direct Comparison with Distribution Share Figure 133. Distributors Profiles Figure 134. Years Considered Figure 135. Research Process Figure 136. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg per Unit
  • 20mg per Unit
  • 30mg per Unit
  • 40mg per Unit
  • 50mg per Unit
  • 60mg per Unit
  • 70mg per Unit
Applications
  • Attention Deficit Hyperactivity Disorder(ADHD)
  • Bulimia
  • Other
Companies covered
  • Zhejiang Huahai Pharmaceutical
  • Sun Pharmaceutical
  • Takeda Pharmaceutical
  • Teva Pharmaceutical
  • Sandoz
  • Mylan
  • Mallinckrodt PLC
  • Lannett
  • Hikma Pharmaceuticals
  • Ascent Pharmaceuticals
  • Apotex
  • Amneal Pharmaceuticals
  • Alkem Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Lisdexamfetamine Dimesylate Capsules Sales Value (2021-2032)
  4. 1.2.2 Global Lisdexamfetamine Dimesylate Capsules Sales Volume (2021-2032)
  5. 1.2.3 Global Lisdexamfetamine Dimesylate Capsules Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Lisdexamfetamine Dimesylate Capsules Market Dynamics
  1. 2.1 Lisdexamfetamine Dimesylate Capsules Industry Trends
  2. 2.2 Lisdexamfetamine Dimesylate Capsules Industry Drivers
  3. 2.3 Lisdexamfetamine Dimesylate Capsules Industry Opportunities and Challenges
  4. 2.4 Lisdexamfetamine Dimesylate Capsules Industry Restraints
3 Lisdexamfetamine Dimesylate Capsules Market by Company
  1. 3.1 Global Lisdexamfetamine Dimesylate Capsules Company Revenue Ranking in 2025
  2. 3.2 Global Lisdexamfetamine Dimesylate Capsules Revenue by Company (2021-2026)
  3. 3.3 Global Lisdexamfetamine Dimesylate Capsules Sales Volume by Company (2021-2026)
  4. 3.4 Global Lisdexamfetamine Dimesylate Capsules Average Price by Company (2021-2026)
  5. 3.5 Global Lisdexamfetamine Dimesylate Capsules Company Ranking (2024-2026)
  6. 3.6 Global Lisdexamfetamine Dimesylate Capsules Company Manufacturing Base and Headquarters
  7. 3.7 Global Lisdexamfetamine Dimesylate Capsules Company Product Type and Application
  8. 3.8 Global Lisdexamfetamine Dimesylate Capsules Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Lisdexamfetamine Dimesylate Capsules Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Lisdexamfetamine Dimesylate Capsules Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Lisdexamfetamine Dimesylate Capsules Market by Type
  1. 4.1 Lisdexamfetamine Dimesylate Capsules Type Introduction
  2. 4.1.1 10mg per Unit
  3. 4.1.2 20mg per Unit
  4. 4.1.3 30mg per Unit
  5. 4.1.4 40mg per Unit
  6. 4.1.5 50mg per Unit
  7. 4.1.6 60mg per Unit
  8. 4.1.7 70mg per Unit
  9. 4.2 Global Lisdexamfetamine Dimesylate Capsules Sales Volume by Type
  10. 4.2.1 Global Lisdexamfetamine Dimesylate Capsules Sales Volume by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global Lisdexamfetamine Dimesylate Capsules Sales Volume by Type (2021-2032)
  12. 4.2.3 Global Lisdexamfetamine Dimesylate Capsules Sales Volume Share by Type (2021-2032)
  13. 4.3 Global Lisdexamfetamine Dimesylate Capsules Sales Value by Type
  14. 4.3.1 Global Lisdexamfetamine Dimesylate Capsules Sales Value by Type (2021 VS 2025 VS 2032)
  15. 4.3.2 Global Lisdexamfetamine Dimesylate Capsules Sales Value by Type (2021-2032)
  16. 4.3.3 Global Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type (2021-2032)
5 Lisdexamfetamine Dimesylate Capsules Market by Application
  1. 5.1 Lisdexamfetamine Dimesylate Capsules Application Introduction
  2. 5.1.1 Attention Deficit Hyperactivity Disorder(ADHD)
  3. 5.1.2 Bulimia
  4. 5.1.3 Other
  5. 5.2 Global Lisdexamfetamine Dimesylate Capsules Sales Volume by Application
  6. 5.2.1 Global Lisdexamfetamine Dimesylate Capsules Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lisdexamfetamine Dimesylate Capsules Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Lisdexamfetamine Dimesylate Capsules Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Lisdexamfetamine Dimesylate Capsules Sales Value by Application
  10. 5.3.1 Global Lisdexamfetamine Dimesylate Capsules Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Lisdexamfetamine Dimesylate Capsules Sales Value by Application (2021-2032)
  12. 5.3.3 Global Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application (2021-2032)
6 Lisdexamfetamine Dimesylate Capsules Regional Sales and Value Analysis
  1. 6.1 Global Lisdexamfetamine Dimesylate Capsules Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Lisdexamfetamine Dimesylate Capsules Sales by Region (2021-2032)
  3. 6.2.1 Global Lisdexamfetamine Dimesylate Capsules Sales by Region: 2021-2026
  4. 6.2.2 Global Lisdexamfetamine Dimesylate Capsules Sales by Region (2027-2032)
  5. 6.3 Global Lisdexamfetamine Dimesylate Capsules Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Lisdexamfetamine Dimesylate Capsules Sales Value by Region (2021-2032)
  7. 6.4.1 Global Lisdexamfetamine Dimesylate Capsules Sales Value by Region: 2021-2026
  8. 6.4.2 Global Lisdexamfetamine Dimesylate Capsules Sales Value by Region (2027-2032)
  9. 6.5 Global Lisdexamfetamine Dimesylate Capsules Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Lisdexamfetamine Dimesylate Capsules Sales Value (2021-2032)
  12. 6.6.2 North America Lisdexamfetamine Dimesylate Capsules Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Lisdexamfetamine Dimesylate Capsules Sales Value (2021-2032)
  15. 6.7.2 Europe Lisdexamfetamine Dimesylate Capsules Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Lisdexamfetamine Dimesylate Capsules Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Lisdexamfetamine Dimesylate Capsules Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Lisdexamfetamine Dimesylate Capsules Sales Value (2021-2032)
  21. 6.9.2 South America Lisdexamfetamine Dimesylate Capsules Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Lisdexamfetamine Dimesylate Capsules Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Lisdexamfetamine Dimesylate Capsules Sales Value Share by Country, 2025 VS 2032
7 Lisdexamfetamine Dimesylate Capsules Country-level Sales and Value Analysis
  1. 7.1 Global Lisdexamfetamine Dimesylate Capsules Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Lisdexamfetamine Dimesylate Capsules Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Lisdexamfetamine Dimesylate Capsules Sales by Country (2021-2032)
  4. 7.3.1 Global Lisdexamfetamine Dimesylate Capsules Sales by Country (2021-2026)
  5. 7.3.2 Global Lisdexamfetamine Dimesylate Capsules Sales by Country (2027-2032)
  6. 7.4 Global Lisdexamfetamine Dimesylate Capsules Sales Value by Country (2021-2032)
  7. 7.4.1 Global Lisdexamfetamine Dimesylate Capsules Sales Value by Country (2021-2026)
  8. 7.4.2 Global Lisdexamfetamine Dimesylate Capsules Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Lisdexamfetamine Dimesylate Capsules Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Lisdexamfetamine Dimesylate Capsules Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Lisdexamfetamine Dimesylate Capsules Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhejiang Huahai Pharmaceutical
  2. 8.1.1 Zhejiang Huahai Pharmaceutical Company Information
  3. 8.1.2 Zhejiang Huahai Pharmaceutical Business Overview
  4. 8.1.3 Zhejiang Huahai Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zhejiang Huahai Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product Portfolio
  6. 8.1.5 Zhejiang Huahai Pharmaceutical Recent Developments
  7. 8.2 Sun Pharmaceutical
  8. 8.2.1 Sun Pharmaceutical Company Information
  9. 8.2.2 Sun Pharmaceutical Business Overview
  10. 8.2.3 Sun Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sun Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product Portfolio
  12. 8.2.5 Sun Pharmaceutical Recent Developments
  13. 8.3 Takeda Pharmaceutical
  14. 8.3.1 Takeda Pharmaceutical Company Information
  15. 8.3.2 Takeda Pharmaceutical Business Overview
  16. 8.3.3 Takeda Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Takeda Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product Portfolio
  18. 8.3.5 Takeda Pharmaceutical Recent Developments
  19. 8.4 Teva Pharmaceutical
  20. 8.4.1 Teva Pharmaceutical Company Information
  21. 8.4.2 Teva Pharmaceutical Business Overview
  22. 8.4.3 Teva Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Teva Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product Portfolio
  24. 8.4.5 Teva Pharmaceutical Recent Developments
  25. 8.5 Sandoz
  26. 8.5.1 Sandoz Company Information
  27. 8.5.2 Sandoz Business Overview
  28. 8.5.3 Sandoz Lisdexamfetamine Dimesylate Capsules Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sandoz Lisdexamfetamine Dimesylate Capsules Product Portfolio
  30. 8.5.5 Sandoz Recent Developments
  31. 8.6 Mylan
  32. 8.6.1 Mylan Company Information
  33. 8.6.2 Mylan Business Overview
  34. 8.6.3 Mylan Lisdexamfetamine Dimesylate Capsules Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Mylan Lisdexamfetamine Dimesylate Capsules Product Portfolio
  36. 8.6.5 Mylan Recent Developments
  37. 8.7 Mallinckrodt PLC
  38. 8.7.1 Mallinckrodt PLC Company Information
  39. 8.7.2 Mallinckrodt PLC Business Overview
  40. 8.7.3 Mallinckrodt PLC Lisdexamfetamine Dimesylate Capsules Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Mallinckrodt PLC Lisdexamfetamine Dimesylate Capsules Product Portfolio
  42. 8.7.5 Mallinckrodt PLC Recent Developments
  43. 8.8 Lannett
  44. 8.8.1 Lannett Company Information
  45. 8.8.2 Lannett Business Overview
  46. 8.8.3 Lannett Lisdexamfetamine Dimesylate Capsules Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Lannett Lisdexamfetamine Dimesylate Capsules Product Portfolio
  48. 8.8.5 Lannett Recent Developments
  49. 8.9 Hikma Pharmaceuticals
  50. 8.9.1 Hikma Pharmaceuticals Company Information
  51. 8.9.2 Hikma Pharmaceuticals Business Overview
  52. 8.9.3 Hikma Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Hikma Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Product Portfolio
  54. 8.9.5 Hikma Pharmaceuticals Recent Developments
  55. 8.10 Ascent Pharmaceuticals
  56. 8.10.1 Ascent Pharmaceuticals Company Information
  57. 8.10.2 Ascent Pharmaceuticals Business Overview
  58. 8.10.3 Ascent Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Ascent Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Product Portfolio
  60. 8.10.5 Ascent Pharmaceuticals Recent Developments
  61. 8.11 Apotex
  62. 8.11.1 Apotex Company Information
  63. 8.11.2 Apotex Business Overview
  64. 8.11.3 Apotex Lisdexamfetamine Dimesylate Capsules Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Apotex Lisdexamfetamine Dimesylate Capsules Product Portfolio
  66. 8.11.5 Apotex Recent Developments
  67. 8.12 Amneal Pharmaceuticals
  68. 8.12.1 Amneal Pharmaceuticals Company Information
  69. 8.12.2 Amneal Pharmaceuticals Business Overview
  70. 8.12.3 Amneal Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Amneal Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Product Portfolio
  72. 8.12.5 Amneal Pharmaceuticals Recent Developments
  73. 8.13 Alkem Laboratories
  74. 8.13.1 Alkem Laboratories Company Information
  75. 8.13.2 Alkem Laboratories Business Overview
  76. 8.13.3 Alkem Laboratories Lisdexamfetamine Dimesylate Capsules Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Alkem Laboratories Lisdexamfetamine Dimesylate Capsules Product Portfolio
  78. 8.13.5 Alkem Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Lisdexamfetamine Dimesylate Capsules Value Chain Analysis
  2. 9.1.1 Lisdexamfetamine Dimesylate Capsules Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Lisdexamfetamine Dimesylate Capsules Sales Mode & Process
  6. 9.2 Lisdexamfetamine Dimesylate Capsules Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Lisdexamfetamine Dimesylate Capsules Distributors
  9. 9.2.3 Lisdexamfetamine Dimesylate Capsules Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst